China’s Hospital Ships Risk Pacific Health Sovereignty
By Malika Knapp
Medical assistance and defence objectives are closely intertwined, with free treatment serving to normalise a foreign military presence while advancing China’s geopolitical aims. But from a health systems perspective, the benefits are immediate but fleeting.
When China’s newest naval hospital ship, the
Silk Road Ark, set sail on its first overseas mission in September 2025, Beijing framed the voyage as a triumph of humanitarianism. Yet the deployment also illustrates a broader pattern: China’s use of medical assistance as an instrument of statecraft. Operating under China’s
Health Silk Road initiative, the floating hospital embarked on a
220-day tour of the South Pacific and Latin America, demonstrating how
health diplomacy is increasingly used to advance China’s broader geostrategic objectives.
China
will soon boast three hospital ships within the world’s largest navy by hull count. Beyond their medical role, these vessels keep military medical personnel
forward-deployed and highly visible, while projecting Chinese soft power into regions long viewed as Australia’s and the United States’ backyard.
The Sovereignty Trade-Off
For Pacific Island Countries (PICs) grappling with workforce shortages, non-communicable diseases and geographic isolation, the arrival of such ships understandably attracts praise—including from Pacific governments themselves. Leaders in Fiji and Tonga publicly
welcomed the visits, emphasising the
immediate benefits delivered to their citizens and framing the missions as examples of constructive international partnership. In Fiji and Tonga
last October, thousands received free consultations and surgeries they might otherwise never have been able to access. For many individuals, especially those requiring complex surgical procedures, the impact may be life-changing: restored mobility, sight, or relief from chronic pain.
However, the very scale and spectacle of the Silk Road Ark obscures a deeper problem: rather than strengthening Pacific health infrastructure, China’s hospital ship missions risk undermining
health sovereignty by reinforcing dependence on external providers.
When the Silk Road Ark docked in Suva
last year, its arrival coincided with the
50th anniversary of diplomatic relations between Fiji and China. Fijian ministers highlighted that more than
3,000 medical treatments and 426 surgeries were delivered during the mission. China’s Ambassador to Fiji, Zhou Jian, went further, portraying the vessel not only as a
boat of life but also a
boat of peace that supports regional security. The visit featured a
joint maritime search-and-rescue exercise between the Chinese and Fijian navies.
Taken together, these elements underscore China’s growing tendency to integrate
medical aid, a tool of soft power, into its broader diplomatic strategy. The Silk Road Ark is not a civilian NGO ship but a commissioned People’s Liberation Army Navy vessel
staffed by military medical personnel. Its stop in Fiji occurred the same week Australia opened an
$83 million Vuvale Maritime Essential Services Centre in Lami, underscoring how healthcare is only one component of broader strategic competition.
The Limits of Medical Diplomacy
Medical assistance and defence objectives are closely intertwined, with free treatment serving to normalise a foreign military presence while advancing China’s geopolitical aims. But from a health systems perspective, the benefits are immediate but fleeting. The ship arrives with Chinese health professionals, performs surgeries on board, tallies impressive numbers, and then sails on. Local doctors and nurses may assist, but there is no evidence of sustained training of local medical staff that would expand Fiji’s own capacity once the white hull disappears over the horizon. Short-term collaboration does not substitute for long-term investment in primary care and local health infrastructure to build self-sufficiency, which underpins genuine health sovereignty.
To be clear, this critique is not unique to China. Many
major donors use highly visible forms of medical diplomacy within their spheres of influence. The Australian Defence Force has deployed field hospitals during
humanitarian disasters in the Indo-Pacific, and the United States Navy has sent hospital ships on outreach missions to the
Caribbean, Central and South America. These efforts can be valuable for recipient countries, particularly in disaster response or in reducing specialist care backlogs.
The key issue, however, is whether short-term service substitution is paired with sustained capacity building. Even when generously provided, temporary replacement of local services does not, on its own, strengthen a country’s health institutions. Without parallel investments in local medical schools, specialist training pathways and health systems, hospital ship missions risk reinforcing dependency.
What Health Sovereignty Requires
Tonga’s experience is illustrative. When the Silk Road Ark visited Nukuʻalofa for a
week-long mission, it offered free specialist services in orthopaedics, dermatology and gastroenterology, alongside a program of cultural performances designed to strengthen ties. For a country where overseas travel is often the only way to access such care, this was welcome relief. But temporary relief cannot be confused with long-term resilience.
Tonga’s core challenges—a limited healthcare workforce, high burden of non-communicable diseases, uneven distribution of health workers across islands and chronic shortages of medicines—cannot be solved by episodic ship visits. If anything, repeated reliance on visiting foreign teams risks entrenching a two-tiered system in which external providers are seen as superior, while local services remain under-resourced and undervalued.
This is the crux of the sovereignty problem.
Health sovereignty is not about rejecting external help; it is about retaining the ability to set priorities, build domestic capacity and deliver care independently over time. Hospital ship missions, whether Chinese or American, are ill-suited to that task when they focus primarily on visible service delivery.
A Health Silk Road aimed at strengthening Pacific health sovereignty would prioritise long-term local capacity building by shifting emphasis from floating hospitals to local institutions: co-funded medical schools, long-term specialist training, regional supply hubs, and sustained support for primary and preventative care. Instead, the Silk Road Ark is a geopolitical tool in China’s health-diplomacy toolkit that serves Beijing’s strategic interests first, while offering Pacific Islanders care that is generous and visible but ultimately temporary.
